Here's your Cheat Sheet to earnings...
Here's your Cheat Sheet to earnings...
Dendreon has performed poorly over the past year. Is this trend likely to continue?
Analysis of Top healthcare Business News: 4 Healthcare Stock Stories for Monday Wellness
Several healthcare companies have allowed growth opportunities slide between their fingers...
A combination of earnings strength and relative strength against competitors is a recipe for success...
Here's what you need to know in the hot healthcare world...
A combination of earnings strength and relative strength against competitors is a recipe for success...
Dendreon's Top Institutional Shareholders for Q4 2012
Here's your Cheat Sheet to earnings...
Celsion recently got clobbered. Is this a red flag or an opportunity?
Friday’s rally was driven by news that more patients are taking the Seattle-based drug manufacturer’s prostate cancer drug...
Your Cheat Sheet to the deals of the week ...
The deals of the day...
Here's why these stocks are moving now...
DNDN is a tricky stock. If you were to relate it to a human condition, you could say that it suffers from manic depression. The highs are tremendous, but you will have to pay for them with extreme lows.
Here's why these healthcare stocks are moving now...
Take a closer look at the new ratings and price targets...
Here's what analysts had to say about these companies today...
Here's a closer look at the company's latest earnings release...
Your Cheat Sheet to the top healthcare business news...
According to documents obtained by Reuters, Dendreon analyzed the data in its key clinical trial for the prostate cancer treatment Provenge differently than their pre-specified goal stipulated...
See which companies are seeing their stock prices at annual lows right now...
Here's why these healthcare stocks are moving now...
Your Cheat Sheet to the top healthcare business news...
Here's why these health stocks are moving now...
The Nasdaq was down 0.65 percent on the day and strands at 3,116. These healthcare stocks helped to move the exchange...
Difficulties still haunt the drug manufacturer as Provenge sells more slowly than expected...
Your Cheat Sheet to the top healthcare business news...
Your Cheat Sheet to the top healthcare business news...